Results 111 to 120 of about 4,617,065 (299)

An Anomalous Internal Oxidation of Dilute Cu-Ni Alloys at 800 °C under 1 atm O2

open access: yesHigh Temperature Materials and Processes, 2012
The oxidation of six Cu-xNi alloys (x = 0.2, 0.6, 1, 2, 3, 4 at.%) was studied at 800 °C under 1 atm O2. All of the binary Cu-Ni alloys underwent an internal oxidation of Ni in the presence of an external scale of Cu2O and CuO, in agreement with the ...
Lu L. Y., Liu L. L., Wang S., Niu Y.
doaj   +1 more source

Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer

open access: yesMolecular Oncology, EarlyView.
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas   +16 more
wiley   +1 more source

Mechanisms and therapeutic opportunities of the ribotoxic stress response in cancer

open access: yesMolecular Oncology, EarlyView.
Cancer cells' high translational demand creates opportunities to therapeutically target ribosome function. Ribosome stalling and collisions activate ZAKα and the ribotoxic stress response (RSR), which can trigger rapid, p53‐independent apoptosis in cancer.
Anastassiya Kim   +7 more
wiley   +1 more source

Degradation of paracetamol by catalytic wet air oxidation and sequential adsorption - Catalytic wet air oxidation on activated carbons [PDF]

open access: yes, 2012
The concern about the fate of pharmaceutical products has raised owing to the increasing contamination of rivers, lakes and groundwater. The aim of this paper is to evaluate two different processes for paracetamol removal. The catalytic wet air oxidation
Quesada-Peñate, Isariebel   +5 more
core   +1 more source

Tailoring the Microstructure and High‐Temperature Stability of CoNiV MEAs Through Chromium Alloying

open access: yesEngineering Reports
The performance and longevity of machines, infrastructure, power plants, and structural components depend heavily on materials with high strength and damage tolerance.
P. Mpofu   +3 more
doaj   +1 more source

The VHL tumor suppressor at the crossroad of protein folding, aggregation, and cancer

open access: yesMolecular Oncology, EarlyView.
Mutations, environmental stress, and chaperone dysfunction can destabilize pVHL, promoting its conversion from the native folded state into amyloid‐like assemblies. This transition may contribute to protein storage, cell dormancy, survival, and drug resistance.
Lara Abad   +2 more
wiley   +1 more source

AEROBIC OXIDATION OF ALKYLAROMATICS TO CORRESPONDING HYDROPEROXIDES CATALYSED BY N‐HYDROXY IMMIDES

open access: yes, 2012
Different N-hydroxyphthalimide (NHPI) derivatives were investigated as catalyst for the aerobic oxidation of alkylaromatics, including cumene, phenylcyclohexane and ethylbenzene, leading to the corresponding hydroperoxides in good yields and high ...
MELONE, LUCIO, C. Punta, S. Prosperini
core  

Kinetic modelling of phenols consumption during polyethylene thermal oxidation [PDF]

open access: yes, 2013
Irganox 1010 stabilized PE was monitored by carbonyl build-up and DSC under oxygen. A scheme for PE stabilization by phenols was implemented and its kinetic parameters were calculated from experimental results.
RICHAUD, Emmanuel
core   +1 more source

High-Temperature Oxidation Behavior of Cu-Si-Y Alloys

open access: yesHigh Temperature Materials and Processes, 2013
The effect of rare-earth element Y on high-temperature oxidation behavior of Cu-Si alloys at 973 and 1073 K in 0.1 MPa flowing pure O2 has been investigated.
Liu Qun   +4 more
doaj   +1 more source

Predictive and prognostic biomarkers of Bacillus Calmette‐Guérin therapy failure in bladder cancer patients: A systematic review

open access: yesMolecular Oncology, EarlyView.
High‐risk bladder cancer is typically treated with Bacillus Calmette‐Guérin (BCG), but 30–40% of patients relapse. No FDA‐ or CE‐approved biomarkers currently predict or prognosticate BCG failure. We systematically reviewed the literature and identified 72 eligible studies, revealing several promising biomarkers associated with BCG treatment response ...
Rui Ribeiro‐Pereira   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy